Defense World
25 Apr 2026, 06:19 UTC · 29w ago
Telomir Pharmaceuticals (NASDAQ:TELO) Trading 1.4% Higher – Here’s What Happened
Impact · against what's priced in
The modest price increase for Telomir Pharmaceuticals is not driven by material fundamental developments. The movement appears to be noise, as the trading volume is significantly below average.
- TELO+0.00
No priced-in read yet
- In context
The stock rose 1.4% to $1.40 on volume that was 33% below the average session volume, indicating a lack of conviction or material catalyst.
Read from the article alone
- Actual

Top 2 movers · tap to explore




